Like other microbial toxins, cholera toxin cannot be used for immunization in its active form because of its potent biological activity. If given orally to experimental animals or man, it may cause the classical diarrheagenic outpouring of fluid in the gut (4, 11, 14, 34) , and, if given parenterally, it will, at the very least, cause reactions at the site of inoculation (10, 13, 24) . For purposes of immunization, then, it is necessary to convert cholera toxin into a stable inactive form (toxoid) which can still produce neutralizing antitoxin in experimental animals and man.
By analogy with diphtheria and tetanus toxoids, purified cholera toxin was detoxified chemically with Formalin. Although complete or nearly complete elimination of detectable toxicity was generally achieved under the conditions used, Craig (personal communication) observed that mice injected intravenously with one such toxoid suffered weight loss or delayed death, or both-events which were usually attributed to toxin. Subsequently, it was confirmed in a number of laboratories that another Formalin toxoid (Wyeth lot 00101) exhibited reactivation both in vivo (24; J. P. Craig On the basis of these observations as well as considerable evidence that some diphtheria (2, 21, 32, 35, 36, 38) and tetanus (1) Formalin toxoids also exhibit reversion to toxicity, it was considered important to explore new methods for detoxification. In order to eliminate the problem of reactivation, it was reasoned that an irreversible chemical modification which eliminated toxicity without adversely affecting antigenicity was required. Glutaraldehyde, a bifunctional dialdehyde, was selected as a feasible reagent to explore since the stability of reaction products obtained by treatment of various proteins with glutaraldehyde has been documented by a number of investigators (3, 16, 17, 26, 29, 30) and since plausible reaction mechanisms have been proposed (17, 20, 33) . The conditions surrounding the preparation of stable, antigenic cholera toxoids by reaction of purified toxin with glutaraldehyde, as well as a preliminary analysis of the reaction products, are the subject of this investigation.
MATERIALS AND METHODS Production and purification of toxin. Puritied toxin was obtained by production and purification procedures previously described (31) .
Measurement of toxin potency. Toxin content of various toxin and toxoid preparations was estimated by the rabbit bluing dose (BD) titration method for vascular permeability activity devised by Craig (6, 8, 9) . Unless specified otherwise, two New Zealand albino rabbits were injected intracutaneously with duplicate or triplicate 0.1-ml volumes of serial twofold dilutions of a sample, and 18 h later the rabbits were injected intravenously with 1% Evans blue dye as previously described (31) . The results are given as BD7/ml, determined from the reciprocal of the sample dilution which yielded a 7-mm bluing lesion in rabbit skin.
Measurement of antitoxin combining power. Toxoid units, a measure of antitoxin combining power, were determined as previously described (31) according to the method of Craig (9) . One toxoid unit was defined as that amount of toxoid capable of binding 1 unit of antitoxin (AU) (9) , and the number of toxoid units was regarded as a measure of the amount of antigen in various toxoid preparations.
In vitro reversion test. Samples of toxoid (2 to 5 ml) in 0.067 M phosphate-buffered saline (PBS), pH 7.8, were incubated in the presence of 0.01% thimerosal at 37 C for 2 weeks before being assayed for toxin activity by the BD titration method described above. Control samples were held at 4 C for 2 weeks and assayed in parallel with the samples incubated at 37 C.
In Titration of levels of antitoxin in immune rabbit sera. The amount of antitoxin in the sera of rabbits immunized with various preparations of toxoid was estimated by the intracutaneous method in rabbits according to the method of Craig (6, 8, 10) , with the exceptions that: (i) sera were inactivated undiluted;
(ii) serial twofold dilutions of sera (in 0.067 M phosphate buffer with 0.01% gelatin, pH 7.4) were incubated with an equal volume of previously standardized toxin containing 1 limit-of-bluing (Lb) dose/ml (9); and (iii) the provisional standard cholera antitoxin (Swiss Serum and Vaccine Institute standard antitoxin containing 4,470 antitoxin units per ml) was tested at 2, 1, 0.5, and 0.25 AU/ml. Bluing was performed as previously described (31) . The results are presentedin AU per milliliter, determined from the reciprocal of the serum dilution which, in the presence of an equal volume of toxin containing 1 Lb dose/ml, yielded a 4-mm bluing lesion in rabbit skin.
Guinea pig immunogenicity test. Immunogenicity of certain toxoids was estimated on the basis of the magnitude of suppression of bluing which occurred when immunized guinea pigs were challenged intracutaneously with graded doses of toxin (7, 9, 12) . Groups of guinea pigs (six animals per group) were immunized intramuscularly with 1 ml containing approximately 1 Ag of a selected toxoid. Three animals from each group were given an identical booster shot 4 weeks after the primary inoculation. Three guinea pigs and an equal number of unimmunized guinea pigs were challenged by intradermal injection of appropriate serial twofold dilutions of toxin 4 weeks after primary immunization; another set of animals were similarly challenged 2 weeks after secondary immunization. The factor of suppression was calculated from the difference in the dilution of toxin challenge required to produce an 8-mm bluing lesion in immunized versus unimmunized guinea pigs.
Ultraviolet absorption spectra. Ultraviolet spectra of selected toxoids in 0.067 M PBS, pH 7.8, were determined by using a Beckman DU spectrophotometer and 1-cm quartz cuvettes.
Acrylamide gel electrophoresis. Acrylamide gel electrophoresis was performed as previously described (31) . Electrophoresis was terminated when the tracking dye reached the bottom of the gel.
Agarose chromatography. Chromatography was performed at room temperature with Bio-Gel A-0.5 M (Bio-Rad, Richmond, Calif.) and a 2.5-by 45-cm column (K25/45, Pharmacia, Piscataway, N.J.). Samples containing 2.5 to 5.0 mg of protein in 2 to 3 ml were applied to the column, and the chromatogram was developed by using 0 concentration of glutaraldehyde was increased from 200 to 400 mol/mol of toxin (Table 1, column 1). In the range of 400 mol of glutaraldehyde per mol of toxin or above, complete elimination of detectable toxicity could be achieved, but with some risk of obtaining either insoluble reaction products or adversely affecting the ability of the antigen to stimulate circulating antitoxin in immunized rabbits (Table 2) . Under conditions in which reaction products retained residual toxicity, prolonged incubation for periods of up to 6 days did not result in any further reduction of activity. To determine whether or not this result could be explained by consumption of the reagent during the course of the reaction, untreated toxin was added to a glutaraldehyde-toxin (200:1, mol/mol) reaction mixture at some point after equilibrium had been reached. Compared with a toxin control which was incubated in PBS under the same conditions, the activity of toxin added to the reaction mixture was significantly reduced after incubation for 5 h (Table 3 ). This result suggested that those molecules which had not undergone detoxification were either inaccessible or resistant to the reagent under the conditions used. In vitro stability studies. Samples of purified toxin (420 ,g/ml) were incubated with 50, 100, 200, and 400 mol of glutaraldehyde per mol of toxin, respectively, at 30 C in PBS, pH 7.8, for 72 h. A sample of the same toxin preparation was incubated with 0.2% Formalin (16,000 mol/ mol of toxin) under identical conditions. After incubation and dialysis, samples of each reaction mixture were removed for in vitro reversion tests, and the bulk solutions were stored at 4 C. Activity assays showed that toxoids prepared by reaction of toxin with 200 or 400 mol of glutaraldehyde per mol of toxin, respectively, did not reactivate after incubation at 37 C for 2 weeks or at 4 C for 6 months (Table 1) . Toxoids prepared by reaction of toxin with 50 or 100 mol of glutaraldehyde per mol of toxin, however, exhibited increases in activity of 10-fold and 4-fold, respectively, after incubation at 37 C for 2 weeks and at some time during incubation at 4 C. Formalin toxoid, on the other hand, exhibited at least a 300-fold increase in activity after incubation at 37 C, while remaining essentially stable at 4 C.
In vivo stability studies. Based on the results of in vitro stability studies, selected toxoids were examined for their ability to reactivate in vivo by using the abbreviated rabbit induration test previously described. Defining reactivation on the basis of the delayed appearance of induration, the data showed that glutaraldehyde toxoids prepared with 200 or more mol of glutaraldehyde (per mol of toxin) did not reactivate in vivo throughout a 14-day observation period, whereas a representative Formalin toxoid did exhibit in vivo reactivation under the same conditions (Fig. 2) . The induration profile produced by toxin alone showed that induration associated with toxoids, whether initial or delayed, was due to the presence of toxin.
Ultraviolet absorption spectra. Since Habeeb and Hiramoto (17) demonstrated a shift in ultraviolet absorption from 280 to 265 nm for glutaraldehyde-modified bovine serum albumin and ovalbumin, respectively, the ultraviolet spectra of selected toxoids were examined in order to detect changes in the chromophoric groups accompanying reaction with glutaralde- after intracutaneous injection of toxin or toxoid. Volume of injection was 0.1 ml, and each sample contained 30 ,g/ml.
per mol of toxin, respectively, exhibited a shift in their ultraviolet absorption maxima from 280 nm towards 260 nm, the extent of which increased with increasing concentrations of glutaraldehyde (Fig. 3 ). There were also correlative increases in the value of E c g, indicating some change in the chromophoric groups. It is noteworthy that there appeared to be a relationship between the extent of the ultraviolet shift (and the magnitude of the increase in E'cm) and the extent of detoxification (Table 1 , column 1; Fig. 3 ), since toxoids prepared with 200 or 400 mol of glutaraldehyde per mol of toxin, which were inactivated to nearly the same extent, exhibited nearly identical ultraviolet absorption spectra. Toxoids, which were not inactivated to the same extent (50 and 100 mol of glutaraldehyde per mol of toxin), however, exhibited a significant difference in the extent of the ultraviolet shift relative to each other as well as relative to the more completely detoxified toxoids.
Acrylamide gel electrophoresis of reaction products. Toxoids comparable to those described above were examined by acrylamide gel electrophoresis. The results showed that: (i) with the exception of the toxoid prepared with 50 mol of glutaraldehyde per mol of toxin, the glutaraldehyde toxoids consisted of multiple species with significantly different electropho- (Fig. 4) . Under the same electrophoretic conditions, the majority of Formalin toxoid molecules co-migrated with the most rapidly moving component of the glutaraldehyde toxoids. (A small percentage of Formalin toxoid molecules sometimes comigrated with the second most rapidly moving species associated with the glutaraldehyde-toxoids.)
Agarose chromatography of reaction products. To determine whether or not the multiple electrophoretic species associated with the glutaraldehyde toxoids were related by charge or by molecular size, a series of toxoids comparable to those described above (Fig. 4) were fractionated by chromatography on BioGel A-0.5 M. The resulting optical density profiles ( Fig. 5) for each of the toxoids showed that the electrophoretic heterogeneity associated with them was due to a distribution of molecular sizes and that the proportion of higher-molecular-weight species increased with increasing concentrations of glutaraldehyde. As in the case of the ultraviolet spectra (Fig. 3) , there appeared to be less difference (in the molecular weight distribution) between the toxoids produced with 200 and 400 mol of glutaraldehyde per mol of toxin than there was between the toxoids produced with 50 and 100 mol of glutaraldehyde per mol of toxin. Also, a comparison of the data in Fig. 5 with that in degree of detoxification and the formation of higher-molecular-weight toxoids.
Acrylamide gel electrophoresis of selected fractions from one of the chromatograms (200: 1, mol/mol; Fig. 5D ) corroborated that the different species were of different molecular weights since the various electrophoretic species migrated on the gels in reverse order to their elution from the column (Fig. 6) .
In addition, it should be noted that the series of toxoids used in ,the chromatography experiments appeared to contain a larger proportion of higher-molecular-weight species than did the toxoids depicted in Fig. 4 (compare staining patterns of acrylamide gels depicted in Fig. 4 and 5). The only known difference between the two sets of toxoids was that the set used for chromatography was prepared 4 to 6 weeks before analysis by chromatography and electrophoresis, whereas the other set of toxoids (Fig.  4) was analyzed by electrophoresis directly after preparation. These results suggest the possibility that some proportion of the reaction products may tend to aggregate or even polymerize (via an exposed aldehyde on the bifunctional glutaraldehyde molecule) during either concentration or prolonged liquid storage at 4 C. None of the toxoids, however, exhibited any insoluble reaction products under these conditions, and residual toxicity levels remained effectively unchanged for at least 6 months (see Table 1 ).
Immunodiffusion properties. Toxoids prepared with 50, 100, 200, and 400 mol of glutaraldehyde per mol of toxin, respectively, were tested against Wyeth goat no. 1 antitoxin (31) along with Formalin toxoid and parent toxin. The results showed that, although all of the glutaraldehyde toxoids formed precipitin lines with antitoxin, the distance of antigen migration and the sharpness of the precipitin lines decreased as the molar ratio of glutaraldehyde to toxin was increased (Fig. 7) . Occasionally, a slight spur was observed on the precipitin line formed by toxin and antitoxin as it merged with the precipitin line formed by the 400:1 (mol/ mol) glutaraldehyde toxoid and antitoxin (barely visible in Fig. 7 ). These observations were consistent with the results showing an increase in molecular weight heterogeneity (Fig.  5 ) and an alteration in antigenicity (Table 2) with increasing concentrations of glutaraldehyde.
On the basis of toxoid unit determinations, glutaraldehyde toxoids prepared with 200 mol of glutaraldehyde per mol of toxin exhibited about a 50% reduction in antitoxin combining power relative to Formalin toxoids (Table 4 ). This observation indicated that some determinant VOL. 9, 1974 groups on the glutaraldehyde toxoid antigen toxin in rabbit skin vascular permeability aswere either altered or masked. Nevertheless, says and they formed a discrete precipitin line rabbit and goat antisera prepared against such of identity when tested against toxin and glutartoxoids were highly effective in neutralizing aldehyde toxoid in double-diffusion tests. Antigenicity. On the basis of their stability, toxoids prepared by reaction of toxin with 200 mol of glutaraldehyde per mol of toxin were selected for antigenicity studies. The ability of these toxoids to elicit circulating antitoxin in rabbits was compared with Formalin toxoid (0.2% Formalin or approximately 16,000 mol per mol of toxin) prepared from the same parent toxin. In addition, the effect of adjuvant on the antigenicity of glutaraldehyde toxoid was also investigated. For this purpose, it was necessary to devise an effective adjuvant system (which would ultimately be suitable for man) because both Formalin and glutaraldehyde toxoids either did not bind to or were rapidly released from preformed aluminum gels at or near physiological pH (R. Rappaport, unpublished data).
For example, no adjuvant effect was observed in rabbit immunization studies comparing the antigenicity of Formalin toxoid with Formalin toxoid bound to an aluminum gel (Reheis F-5000) at pH 5.5 (Table 5 ). In vitro studies (radial immunodiffusion and protein determinations) corroborated that approximately 70% of the antigen was bound to the gel at pH 5.5, but that the bulk of it was released upon adjustment of the gel suspension to pH 7 ( Fig. 8) . Although less antigen was bound above pH 5.5, similar adsorption and release (at pH 7.5) properties were observed (Fig. 8) .
To promote binding of the negatively charged toxoids to aluminum gels, protamine sulfate was used. It was reasoned that the presence of a preponderance of basic amino acids in the protamines might favor an interaction between them and the acidic toxoids and that such a complex might be more readily bound by aluminum gels at or near physiological pH.
Aluminum phosphate gels were prepared in situ by using aluminum chloride (with or without protamine) as the diluent for lyophilized PBS buffer (pH 7.8) and toxoid antigen. A turbid suspension was formed instantaneously when 500 jig of dried glutaraldehyde toxoid (plus PBS salts) was rehydrated with 5 ml of a clear aqueous solution containing 0. <2 (5) 47 (5) 233 (5) 649 (5) 421 (5) 123 (5) (5) 33 (5) 109 (5) 484 (5) 236 (5) 78 (5) 46 (5) a Determined as described in Materials and Methods. Numbers indicate geometric mean titers. Numbers in parentheses indicate the number of rabbits. (7) 242 (6) 46 (6) 27 (6) 27 (6) (7) 147 (7) 2031 (7) 402 (7) 164 (6) 139 (5) (7) 706 (7) 204 (7) 169 (7) 113 (7) (Table 7 ). In the same test, guinea pigs immunized with approximately 1 ,ug of Formalin toxoid exhibited about a twofold suppression of bluing 4 weeks after primary immunization and a 50-fold suppression of bluing 2 weeks after secondary immunization (Table 7) . DISCUSSION The purpose of this investigation was to develop a reliable method for preparing stable antigenic toxoids for ultimate use in human immunization programs. In view of the instability of cholera Formalin toxoids as observed in this laboratory, a series of new toxoids prepared by reaction of' purif'ied toxin with glutaraldehyde was evaluated in terms of three criteria: (i) residual toxicity; (ii) in vitro and in vivo stability; and (iii) ability to elicit neutralizing antitoxin in animal models.
In establishing optimal conditions for detoxification, the availability of a sensitive biological assay (the rabbit skin vascular permeability test [6, 8, 9 ] ), capable of detecting as little as 0.1 to 0.5 ng of toxin, permitted the determination of trace amounts of residual toxicity. By using this assay to monitor the reaction between toxin and glutaraldehyde, it was observed that the extent of detoxification was determined by the relative concentrations of each component. When conditions were such that the concentration of toxin was between 400 and 600 ,g/ml and the molar ratio of glutaraldehyde to toxin was between 200: 1 and 400: 1, soluble reaction products were obtained and nearly complete elimination of toxicity was achieved. Under these conditions, the glutaraldehyde toxoids were characterized by a molecular heterogeneity which was absent from Formalin toxoids.
The results of electrophoresis and molecular sieve chromatography, in fact, suggested a relationship between the extent of detoxification and the formation of higher-molecular-weight toxoids, since levels of residual toxicity decreased and molecular heterogeneity increased as the molar ratio of glutaraldehyde to toxin was elevated from 50: 1 to 400: 1.
In the absence of prior knowledge about the immunogenic properties of glutaraldehyde toxoids, the selection of reaction conditions which favored the production of a toxoid with minimal detectable toxicity appeared to be a reliable approach to preventing structural modification of the toxoid molecules (such as might occur if extensive reaction between toxin and glutaraldehyde were allowed to take place). Because rabbit immunization studies showed that toxoids prepared with 400 or more mol of glutaraldehyde per mol of toxin were less antigenic than toxoids prepared with 200 mol of glutaraldehyde (Table 2) , the latter toxoids were selected for further study. Although these toxoids exhibited slight residual toxicity, it should be noted that such toxicity was generally detectable only when the concentration of toxoid was at least fivefold greater than the maximal dose anticipated for animal or human immunization (100 ztg). Quantitatively, the aforementioned (200 molar) glutaraldehyde toxoids contained no more than 20 BD7 per 100 ,gg, or, on the basis of data reported by Craig (9) In evaluating the stability of toxoids obtained by reaction of toxin with various molar ratios of glutaraldehyde, it was observed that significant levels of residual toxicity remained associated with toxoids prepared with 50 or 100 mol of glutaraldehyde per mol of toxin. Since these toxoids were not suf'ficiently detoxified to warrant their use as immunogens, their stability in vivo was not carefully investigated. Questions pertaining to their ability to reactivate under physiological conditions, therefore, remain unresolved. In vitro reversion studies, however, suggested that these toxoids were not completely stable since vascular permeability assays performed at different times after incubation at 4 or 37 C showed increases in toxicity of as much as 10-fold (see Table 1 ). Although Craig (9) Table 1 ), under conditions where the molar concentration of Formalin was 320 times greater than glutaraldehyde, indicated a difference in the respective reaction mechanisms. Further, on the basis of the in vitro reversion data (Table 1) , it was estimated that reactivation, when it occurred, was limited to between 0.1 and 1.0% of the molecules for both glutaraldehyde and Formalin toxoids. It is possible that these molecules differ chemically from the majority of the toxin molecules and that they represent a subpopulation more resistant to detoxification. The existence of such a population was, in fact, suggested by the inactivation curve (following the reaction of 580 ,ug/ml of toxin with 200 mol of glutaraldehyde) which departed from linearity after a 3-log reduction in toxicity (see Fig. 1 ).
In contrast to toxoids with significant residual toxicity, the stability of toxoids with minimal toxicity, such as those prepared with 200 or 400 mol of glutaraldehyde per mol of toxin, was studied intensively. These toxoids reproducibly did not exhibit any in vitro reactivation when tested at intervals during storage for at least 6 months. Further, such toxoids did not exhibit any reactivation in rabbit in vivo reversion tests as they were performed in this laboratory, or in in vivo reversion tests performed independently in rabbits and mice by Craig (personal communication), or in monkeys by R. Northrup and F. Chisari (personal communication).
Having satisfied the two criteria of low residual toxicity and stability, glutaraldehyde toxoids prepared with 200 mol of glutaraldehyde per mol of toxin were selected for evaluation of the third criterion-the ability to elicit antitoxin or protection against toxin challenge in animal models. In the present study, glutaraldehyde toxoid (with and without adjuvant) was compared with Formalin toxoid since the antigenicity of the latter toxoid has been demonstrated repeatedly (7, 12, 15, 18, 28) .
From the standpoint of both magnitude and duration of circulating antitoxin in immunized rabbits, the results showed that glutaraldehyde toxoid plus adjuvant was as antigenic as Formalin toxoid and approximately six times more antigenic than glutaraldehyde toxoid alone. It was also observed that, irrespective of whether it was administered with or without adjuvant, glutaraldehyde toxoid reproducibly elicited a sharper anamnestic response than did Formalin toxoid. In addition, long-term surveillance of rabbits immunized twice with 100 jg of glutaraldehyde toxoid plus adjuvant (with a 6-week interval between inoculations) showed that measurable antitoxin persisted for at least 48 weeks and that the antitoxin titers were raised more thin 100-fold 2 weeks after a booster inoculation (R. RAppaport, unpublished data). Provided that circulating antitoxin is a measure of protection, these findings indicate that a vaccine composed of a toxoid antigen may, unlike the classical cholera vibrio vaccine, offer long-term immunity.
In terms of the ability to protect immunized guinea pigs against toxin skin challenge, glutaraldehyde toxoid plus adjuvant was at least as effective as Formalin toxoid. It is noteworthy that the comparative immune response elicited by these toxoids in guinea pigs was similar to the response observed in rabbits, even though the sensitivity of the guinea pig test allowed the antigen dose to be reduced 100-fold. The observation that glutaraldehyde toxoid alone (0.73-jig dose) was ineffective in eliciting suppression of toxin challenge was regarded as evidence that less than 1 immune response in this system.)
In both the rabbit and guinea pig models, the enhancement of the immune response produced by the addition of adjuvant to glutaraldehyde toxoid not only reflected the effectiveness of the adjuvant system but also demonstrated the inherent antigenicity of the toxoid. The fact that glutaraldehyde toxoid alone was not nearly as effective an antigen as Formalin toxoid is most probably related to the observation that Formalin texoid reactivated in vivo, whereas glutaraldehyde toxoid did not. This phenomenon means that comparative antigenicity studies such as those presently described are, in effect, measuring the relative antigenicity of toxoid versus toxoid plus toxin.
On the basis of in vitro reversion data, and assuming a comparable degree of reversion in vivo, the amount of toxin released by 100 jig of Formalin toxoid was estimated to be on the order of 2 to 5 Lb doses. This amount of toxin represents approximately 100 times more than the amount of residual toxin associated with glutaraldehyde toxoid, and it appears either to be released gradually or to exert its biological effect gradually (over a period of days) at the site of inoculation (see Fig. 2 ).
Since it has been postulated that cholera toxin, which produces prolonged stimulation of cyclic adenosine monophosphate-mediated processes in various tissues (27, 37, 40) , may enhance antibody response either by activating cyclic adenosine monophosphate-mediated mechanisms in immunocompetent cells (5) or by stimulating cellular infiltration at the site of inoculation (24, 25, 28) 
